InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Berk Gregory, 董事. Officer active across 1 company, notably GT Biopharma, Inc.. In total, 1 reports have been logged. Activity tracked since 16 February 2021. The latest transaction was filed on 16 February 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Gregory Berk is a Board Member at GT Biopharma, Inc. He participates in the governance of the company, which focuses on developing innovative treatments in biopharmaceuticals. His role is essential in guiding the strategy and operations of GT Biopharma.